Skip to content

Effectiveness of lingual nerve block in preventing heart rate and blood pressure surges during tongue cancer surgeries

Efficacy of lingual nerve block in preventing hemodynamic response due to surgical stimulation in patients undergoing tongue cancer resections.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/049309
Enrollment
146
Registered
2023-01-31
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C029- Malignant neoplasm of tongue, unspecified

Interventions

Intervention1: Lingual nerve block with 2% lignocaine.: 2% lignocaine (in lingual block group) will be infiltrated near the lingual nerve by the surgeon prior to tongue incision.The point of insertion

Sponsors

Dr Shalini Chaudhuri
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to participate and sign the informed consent form 2.Age-18 years to 60 years 3. ASA 1 and 2 patients 4. Both sexes 5. Patients posted for wide local excision of unilateral tongue cancer lesions with or without neck dissection.

Exclusion criteria

Exclusion criteria: 1. Patient not consenting to study. 2. Extensive lesions requiring near total or total glossectomy or requiring incision on posterior 1/3rd of tongue. 3. Patients with known allergy to lignocaine. 4. Pregnant patients. 5. Mentally challenged patients unable to understand and give informed risk consent.

Design outcomes

Primary

MeasureTime frame
The primary outcome parameter will be the maximum heart rate and maximum mean arterial pressure during primary tumour excision.Timepoint: At every 2 minutes interval during excision of primary tumour.

Secondary

MeasureTime frame
The secondary outcome parameters will be the opioid consumption in both groups, the anaesthetic consumption in both groups reflected by the MAC total during the period of primary tumour excision.Timepoint: During excision of primary tumour.

Countries

India

Contacts

Public ContactDr Shalini Chaudhuri

MPMMCC&HBCH, Varanasi

shalinichaudhuri@gmail.com9800066637

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026